Percentage of eligible patients who received HIV tests, plus percentages offered, accepted and HIV prevalence in those tested: summary results from random effects model meta-analysis patient group
| Patient group | Percentage of those eligible who received HIV test (95% CI) | N studies | Percentage of those eligible who were offered HIV test (95% CI) | N studies | Percentage of those offered HIV test who accepted (95% CI) | N studies | Percentage of those tested who were HIV-positive (95% CI) | N studies |
|---|---|---|---|---|---|---|---|---|
| Patients diagnosed with indicator disease | 22.4% (13.9% to 30.9%) | 10 | 9.3% (1.2% to 17.3%) | 2 | 87.4% (57.7% to 100%) | 2 | 2.7% (1.1% to 4.4%) | 6 |
| Persons attending screening settings | 29.5% (23.6% to 35.4%) | 20 | 45.5% (28% to 63%) | 12 | 69.2% (52.7% to 85.6%) | 12 | 0.4% (0.2% to 0.6%) | 17 |
| Overall | 27.2% (22.4% to 32%) I2=99.9% | 30 | 40.4% (24.3% to 56.7%) I2=100% | 14 | 71.5% (50% to 86.9%) I2=99.8% | 14 | 0.5% (0.3% to 0.7%) I2=51.5% | 23 |
95% CIs were bounded to between 0.00% and 100.00% as data are presented as a percentage. For test strategy and type of HIV test, some studies were excluded from the subgroup analyses due to lack of data.